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Opportunities and challenges for HIV self-testing in China
Each hour of 2017, about 220 HIV self-test kits 
(110 packages) were sold by a single online pharmaceutical 
store in China. In addition, eight community-based 
organisations in seven Chinese provinces are working 
with local centres for disease control and prevention 
(CDC) to develop self-testing scale-up pilot programmes 
(figure) among men who have sex with men (MSM).1 
For example, in Zhuhai—a small city with more than 
12 000 MSM—782 self-testing kits were distributed by a 
local community-based organisation in the first 3 months 
of 2018 (93·3% of the testing results were reported back). 
In addition, there was a high HIV self-testing (HIVST) 
demand and uptake among Chinese MSM. For example, 
around 29% of Chinese MSM had already used self-
testing,2 and 593 (49%) of 1219 MSM in a trial used self-
testing between August, 2016, and July, 2017.3
The rapid expansion of HIVST among MSM has 
captured the attention of the Chinese government. The 
State Council of China issued the Thirteenth Five-Year Plan 
(2017–22) for HIV prevention and control in 2017 and 
indicated that China will “explore strategies to promote 
HIVST through selling kits in pharmacies and online”. 
Meanwhile, the National Center for AIDS/STD Control, 
China CDC, is planning to pilot HIVST programmes 
in 20 Chinese cities, and the Chinese STD and AIDS 
Association is collaborating with six community-based 
organisations to develop different testing strategies. 
However, the Chinese Government has also met with a 
few challenges in self-testing expansion among MSM, 
a population with high HIV prevalence and low testing 
rate in China.4
First, China still lacks quality assurance on HIV 
self-test kits. Presently, the Chinese State Food and 
Drug Administration (CSFDA) has only approved one 
oral testing kit for self-testing. Uncertainty exists about 
accuracy of self-testing kits, especially those sold online 
in China. Take the kits sold on Taobao (a Chinese online 
shopping website), for example: most kits were blood-
based rapid-testing kits for clinical use rather than for 
self-testing, without monitoring from the CSFDA.2 
The National Center for AIDS/STD Control did an online 
Figure: A poster used to promote HIV self-testing
“Bring testing home — self-testing HIV kit, follow your desire, follow your heart, 
follow your movement”.
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survey among 54 785 people who purchased of kits 
online. Overall, 150 (0·27%) people who self-tested 
positive for HIV responded to the survey and sent their 
blood samples to a laboratory for confirmation testing. 
Of those, 97 of 150 people were confirmed positive, 
giving an accuracy of 64·7%.5 Evidence shows self-
testers can accurately use rapid diagnostic tests,6 and 
the Chinese Government should approve some quality 
assured rapid testing kits for HIVST and prioritise 
development of policies for the use of these kits.
Second, China has no national guideline to promote 
HIVST. Although China CDC and the China STD and AIDS 
Association started to focus on improving HIVST, and 
have piloted it in multiple cities, a national plan and 
guidelines for the development of policies and strategies 
for HIVST promotion, delivery of kits, and linkage to care 
service remain absent. Local authorities and community-
based organisations therefore lack guidance in spreading 
self-testing, which could further temper the enthusiasm 
of stakeholders in initiating additional programmes.
Third, sustainability of current HIVST programmes 
remains a concern. The pilot programmes are usually 
initiated by local community-based organisations, with 
funding support from local centres for disease control. 
The sustainability of these programmes is jeopardised 
by the low capacity of the local community-based 
organisations, the limited funding, and the absence of 
national guidance on HIVST. Development of a plan to 
maintain sustainability of programmes should be listed 
as one of the top AIDS control priorities of China, and 
empowerment of local community-based organisations 
by improving their capacity would be essential.
China also faces several challenges in common with 
other countries, which include but are not limited to 
missing linkage (even though China has already piloted 
online-to-offline linkage-to-care models), safety, co-
erced testing, and legality.1,7,8
HIV/AIDS control in China already faces many 
challenges, and now HIVST-related challenges are 
added to the list. However, self-testing offers an 
outstanding opportunity for further expansion of 
testing coverage, identifying people living with HIV 
who are unaware of their infection, and linking more 
cases to care. The provision of approved reliable testing 
kits, national HIVST guidelines, and increasing support 
to local community-based organisations will be crucial 
for achieving the first of the 90-90-90 targets. These 
measures should be in place soon to maximise the 
benefits of HIVST.
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